Arcus Biosciences Inc
(RCUS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 53,000 | -226,538 | -148,563 | -72,593 | -123,000 |
| Depreciation Amortization | 9,000 | 5,387 | 3,032 | 1,306 | 3,000 |
| Accounts receivable | -17,000 | 178 | -526 | -4,186 | -1,000 |
| Accounts payable and accrued liabilities | -5,000 | -5,424 | -3,569 | 7,722 | 9,000 |
| Other Working Capital | -376,000 | -15,331 | -22,025 | -8,328 | 208,000 |
| Other Operating Activity | 80,000 | 47,660 | 31,340 | 9,763 | 15,000 |
| Operating Cash Flow | $-256,000 | $-194,068 | $-140,311 | $-66,316 | $111,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -29,000 | -5,210 | 75,543 | 66,467 | -431,000 |
| PPE Investments | -26,000 | -17,572 | -9,714 | -3,641 | -3,000 |
| Sale Of Investment | 51,000 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-4,000 | $-22,782 | $65,829 | $62,826 | $-434,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 232,000 | 225,675 | 224,357 | 222,120 | 439,000 |
| Common Stock Repurchased | N/A | -6 | -6 | N/A | N/A |
| Other Financing Activity | 5,000 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $237,000 | $225,669 | $224,351 | $222,120 | $439,000 |
| Beginning Cash Position | 174,000 | 173,618 | 173,618 | 173,618 | 58,000 |
| End Cash Position | 151,000 | 182,437 | 323,487 | 392,248 | 174,000 |
| Net Cash Flow | $-23,000 | $8,819 | $149,869 | $218,630 | $116,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -256,000 | -194,068 | -140,311 | -66,316 | 111,000 |
| Capital Expenditure | -26,000 | -17,572 | -9,714 | -3,641 | -3,000 |
| Free Cash Flow | -282,000 | -211,640 | -150,025 | -69,957 | 108,000 |